跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 39 条关于
“SOCS1”
全部
39
临床试验
11
药物
21
机构
0
资讯
7
去年
KSQ Therapeutics' CRISPR-Engineered TIL Therapy, KSQ-004EX, Receives FDA IND Clearance for Advanced Solid Tumors
去年
First Patient Dosed in Phase 1/2 Trial of KSQ-004EX CRISPR-Engineered TIL Therapy for Advanced Solid Tumors
去年
Gene Editing Advances: Intellia, Poseida, YolTech, and KSQ Therapeutics Report Clinical Trial Updates
去年
Tumor-Infiltrating Lymphocyte Therapy Market Poised for Explosive Growth Following First FDA Approval
9个月前
Tumor-Associated Macrophages Drive Gastric Cancer Progression Through Immune Evasion and Therapeutic Resistance
去年
Bayer Initiates Phase I Trial of SOS1 Inhibitor BAY3498264 for Advanced KRAS-Mutated Tumors
3个月前
Lupin's Novel SOS1 Inhibitor LNP8701 Shows Promising Safety Profile in Phase 1 Solid Tumor Trial